This is a notice of intent for a sole source award to Life Technologies Corporation for reagent kits used for clinical testing at the National Institutes of Health (NIH) Clinical Center. Life Technologies is the sole manufacturer and vendor for the existing instrumentation. The acquisition is being conducted under FAR Part 13 simplified acquisition procedures. Interested parties can submit their capabilities by March 25, 2026, 9 AM EST.
The bid notice does not specify a delivery deadline.
The bid notice does not specify payment terms.
The bid notice does not specify warranty information.
The bid notice states that the award will be on a firm fixed price sole source award basis.
The bid notice does not explicitly state qualification criteria for interested parties, but mentions that Life Technologies Corporation is the sole manufacturer, vendor, and service provider for existing instrumentation.
The bid notice does not specify any penalties.
The bid notice does not mention the possibility of a site visit.
The bid notice does not require sample submission.
The bid notice states that comments to this announcement may be submitted prior to the closing date specified in this announcement, which is March 25, 2026, at 9 AM EST.
The bid notice does not specify an estimated total value.